Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
G1 Therapeutics, Inc. | Chief Financial Officer | Common Stock | 0 | $0 | $2.51 | Sep 18, 2024 | Direct |
G1 Therapeutics, Inc. | Chief Financial Officer | Stock Option (right to buy) | 0 | Sep 18, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GTHX | G1 Therapeutics, Inc. | Sep 18, 2024 | 5 | $0 | 4 | Sep 18, 2024 | Chief Financial Officer |
GTHX | G1 Therapeutics, Inc. | Jul 5, 2024 | 1 | -$1.32K | 4 | Jul 8, 2024 | Chief Financial Officer |
GTHX | G1 Therapeutics, Inc. | Jul 1, 2024 | 1 | $0 | 4 | Jul 3, 2024 | Chief Financial Officer |
GTHX | G1 Therapeutics, Inc. | May 13, 2024 | 1 | -$39K | 4 | May 15, 2024 | Chief Financial Officer |
GTHX | G1 Therapeutics, Inc. | Mar 20, 2024 | 1 | $0 | 4 | Mar 22, 2024 | Chief Financial Officer |
GTHX | G1 Therapeutics, Inc. | Mar 18, 2024 | 1 | -$19.8K | 4 | Mar 20, 2024 | Chief Financial Officer |
GTHX | G1 Therapeutics, Inc. | Jan 3, 2024 | 5 | -$2.3K | 4 | Jan 8, 2024 | Chief Financial Officer |
GTHX | G1 Therapeutics, Inc. | May 10, 2023 | 1 | $0 | 4 | May 12, 2023 | Chief Financial Officer |
GTHX | G1 Therapeutics, Inc. | Mar 15, 2023 | 2 | $0 | 4 | Mar 17, 2023 | Chief Financial Officer |
GTHX | G1 Therapeutics, Inc. | Mar 15, 2023 | 0 | $0 | 3 | Mar 17, 2023 | Chief Financial Officer |